Abstract:ctive: Benzothiazole and imidazo[2,1- b ][1,3,4]thiadiazole derivatives are the most important pharmacophores and intermediates for making drugs. This study focuses on the preparation and anti-cancer activity of novel benzothiazole-based imidazo[2,1- b ][1,3,4]thiadiazole scaffolds. Methods: The synthesized benzothiazolebased imidazo[2,1- b ][1,3,4]thiadiazole scaffolds ( Va–Vi ) were evaluated. The anticancer activity of ( Va–Vi ) against MCF-7 and A549 cell lines was determined using the MTT assay and screened with in silico molecular docking studies. Results and Discussion: Compounds 2-(6-(4-chlorophenyl)imidazo[2,1- b ][1,3,4]thiadiazol-2-yl)benzo[ d ]thiazole ( Vb ), 2-(6-(4-bromophenyl)imidazo[2,1- b ][1,3,4]thiadiazol-2-yl)benzo[ d ]thiazole ( Vd ), and 2-(6-(4nitrophenyl)imidazo[2,1- b ][1,3,4]thiadiazol-2-yl)benzo[ d ]thiazole ( Vh ) exhibited the most potent anticancer activity against MCF-7 and A549 cancer cell lines. Molecular docking studies of all synthesized compounds and erlotinib were also carried out on the EGFR receptor, showing that compounds ( Vb ), ( Vd ), and ( Vh ) had significantly higher binding scores and inhibitory constants than the reference drug erlotinib. Conclusions: It has been observed that the substitution on the 4-chlorophenyl ring ( Vb ), 4-bromophenyl ring ( Vd ), and 4-nitrophenyl ring ( Vh ) is important for maintaining their anticancer activity. The outcomes of the kinase inhibitory assay of these significant ( Vb ), ( Vd ), and ( Vh ) hybrids against the tyrosine kinase EGFR strongly corroborated the in vitro anticancer findings and the in silico docking investigations. The investigation demonstrated that the newly synthesized compounds have the potential as anticancer agents and provided leads for further development.

Synthesis and Biological Activities of 2-Amino-thiazole-5-carboxylic Acid Phenylamide Derivatives.

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Synthesis and anticancer activity of 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-arylacetamides

Synthesis, Biological Evaluation, and Molecular Docking Studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline Derivatives As Novel Anticancer Agents

Synthesis, Biological Evaluation and Molecular Docking Studies of 1,3,4-Thiadiazole Derivatives Containing 1,4-Benzodioxan As Potential Antitumor Agents

Design, Synthesis and Biological Evaluation of N-arylphenyl-2,2-dichloroacetamide Analogues As Anti-Cancer Agents.

Synthesis and Cytotoxic Activity of Some Novel N-Pyridinyl-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide Derivatives

Rational synthesis and evaluation of 2,4-diamino-thieno[2,3-d]pyrimidines as antitumor agents

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Synthesis, Biological Evaluation, and Molecular Docking Studies of 1,3,4-Thiadiazol-2-amide Derivatives As Novel Anticancer Agents

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.

Quantum chemical treatment, electronic energy in various solvents, spectroscopic, molecular docking and dynamic simulation studies of 2-amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide: A core of anticancer drug

Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives

Synthesis and molecular docking of some new thiazolidinone and thiadiazole derivatives as anticancer agents

Synthesis and Biological Evaluation of 2-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)benzo[d]thiazole Derivatives as EGFR Targeting Anticancer Agents

Discovery of (S)-N-(2-amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6h)-yl)ethyl)benzamide As Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate.

New 1,3,4-Thiadiazole Derivatives with Anticancer Activity

Discovery and Optimization of Novel Dual Dithiocarbamates As Potent Anticancer Agents.

Synthesis, molecular modelling and biological significance of N-(4-(4-bromophenyl) thiazol-2-yl)-2-chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents